Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
245.00
+32.00 (15.02%)
Last updated: Apr 24, 2026, 2:17 PM HKT
Market Cap16.76B
Revenue (ttm)648.05M +24.8%
Net Income197.00M
EPS2.83
Shares Out78.71M
PE Ratio75.15
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume618,960
Average Volume514,701
Open213.40
Previous Close213.00
Day's Range210.80 - 246.00
52-Week Range97.50 - 245.00
Betan/a
RSI70.51
Earnings DateMar 30, 2026

About HKG:2637

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2012
Employees 164
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2637
Full Company Profile

Financial Performance

In 2025, HKG:2637's revenue was 582.36 million, an increase of 24.79% compared to the previous year's 466.68 million. Earnings were 177.03 million, an increase of 30.09%.

Financial numbers in CNY Financial Statements